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Abstract
Given the role of CD247 in the response of the T cells, its entailment in autoimmune diseases and in order to better clarify
the role of this gene in RA susceptibility, we aimed to analyze CD247 gene variants previously associated with other
autoimmune diseases (rs1052237, rs2056626 and rs864537) in a large independent European Caucasian population.
However, no evidence of association was found for the analyzed CD247 single-nucleotide polymorphisms (SNPs) with RA
and with the presence/absence of anti-cyclic citrullinated polypeptide. We performed a meta-analysis including previously
published GWAS data from the rs864537 variant, revealing an overall genome-wide significant association between this
CD247 SNP and RA with anti-CCP (OR= 0.90, CI 95%= 0.87–0.93, Poverall = 2.1610
210). Our results show for first time a GWAS-
level association between this CD247 polymorphism and RA risk.
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Introduction
The T-cell receptor T3 zeta chain (CD3f), also called CD247, is
essential for assembly, surface expression and signaling cascade of
the T-cell receptor-CD3 (TCR/CD3) complex. Abnormalities in
this pathway can result in T-cell dysfunction and development of
autoimmune disorders [1]. Regarding this, previous reports have
demonstrated an association of CD247 variants with systemic lupus
erythematosus [2,3] and systemic sclerosis [4,5]. In the case of
rheumatoid arthritis (RA), one meta-GWAS found no association
between the CD247 gene and RA at a genome-wide significance
level [6]; however, a more recent meta-analysis of GWAS data
from RA and celiac disease (CeD) identified CD247 as a novel
susceptibility locus for both diseases [7]. Taking into account the
role of CD247 in the response of the T-cells, its entailment in
autoimmune diseases and in order to better clarify the role of this
gene in RA susceptibility, we aimed to analyze CD247 gene
variants in a large independent European Caucasian cohort.
Materials and Methods
A large independent European Caucasian cohort containing
cases from four different countries has been included in the present
study. The individuals were recruited from hospitals of Spain
(1,797 cases and 2,026 controls), Germany (326 cases and 379
controls), Norway (949 cases and 1,121 controls) and Australasian
(488 cases and 508 controls). All cases were ascertained by the
American College of Rheumatology criteria [8]. Briefly, the 75%
of the patients were females, the 76% were rheumatoid factor (RF)
positive and the 63% were anti-cyclic citrullinated polypeptide
(anti-CCP) positive. Controls self- reported as not having RA.
All subjects provide written informed consent according to the
declaration of Helsinki. The study was approved by the ethical
committees from all the Spanish participating centers to Galicia,
Madrid (Hospital Clı´nico San Carlos, Hospital La Paz and
Hospital de La Princesa), Barcelona (Hospital Universitario
Bellvitge) and Santander (Hospital Universitario Marque´s de
Valdecilla). In addition, the ethical committees of Medizinische
Hochschule Hannover from Germany, the Regional Committees
for Research Ethics in Eastern and Southern Norway and the
Multi-region Ethics Committee and the Lower South Ethics
Committee of New Zealand also approved the study.
Three CD247 single-nucleotide polymorphisms (SNPs) previ-
ously associated with different autoimmune diseases including RA
were selected: rs1052237 [2,3], rs2056626 [5] and rs864537 [7],
and genotyped using TaqMan assays. A total of 350 patients were
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genotyped twice to verify the genotyping consistency, showing
99% identical genotypes.
In order to increase the robustness of our analyses, we
conducted a meta-analysis with previously published data. The
searching of the articles was performed on MEDLINE and
PUBMED electronic databases. Studies for the meta-analysis were
selected if they met the following conditions: 1) RA patients
fulfilled the ACR criteria of 1988; 2) data were collected in
European Caucasian populations; 3) they included any of the three
polymorphisms selected in the present study. Given these
considerations, only two articles were included in our study [6,7].
The Hardy-Weinberg equilibrium (HWE) was tested by the
means of x2 or Fisher’s exact test when necessary. The case-
control association study was performed by 262 contingency table
with x2 to obtain P-values, odds ratios (OR) and 95% confidence
intervals (CI). Combined ORs were calculated according to a
fixed-effects model (Mantel–Haenszel meta-analysis) and the
heterogeneity of ORs among all populations was calculated by
Breslow-Day test. P values lower than 0.0007 were regarded as
significant after applying the Bonferroni correction. Statistical
analyses were carried out with Plink v1.7 [9] (see URL: http://
pngu.mgh.harvard.edu/˜purcell/plink/) and StatsDirect software
v2.4.6.
The estimation of the power of the study to detect an effect of a
polymorphism in disease susceptibility was performed using the
the CaTS Power Calculator software [10] (see URL: http://www.
sph.umich.edu/csg/abecasis/CaTS).
Results and Discussion
The estimated power of the study was 61% for rs1052237 and
82% for rs2056626 and rs864537 to detect ORs= 1.10 at the 5%
significant level. The genotyping call-rate success was 98.3% in
cases and 99.0% in controls for rs1052231, 97.9% in cases and
96.9% in controls for rs864537 and 97.6% in cases and 96.4% in
controls for rs2056626. Genotype frequencies were in HWE in
cases and controls. The distribution of genotypic and allelic
frequencies for each population is shown in Table S1. We did not
observe any significant association after the multiple testing
correction was applied. However, the meta-analysis of the four
cohorts using the Mantel-Hanzel method under fixed effects
model showed no evidence of association of the three CD247 SNPs
and RA (rs1052231: OR=1.02, CI 95%=0.94–1.20, p = 0.595;
rs864537: OR=0.97, CI 95%=0.91–1.03, p = 0.330; rs2056626:
OR=0.97, CI 95%=0.91–1.04, p = 0.348) (see Table 1). The
combinability test according to the Breslow-Day method showed
no significant heterogeneity among the ORs of the different
cohorts. Moreover, no evidence of association was observed after
stratification for RF and anti-CCP status (Table 1 and Supplementary
Table 1).
In addition to these analyses, we performed a meta-analysis
including published GWAS data for rs864537 [6,7]. Considering
that these studies included auto-antibody-positive RA individuals,
we performed the combined analysis including only RA patients
with anti-CCP. The data of these GWASs together with our
combined data sets revealed an overall genome-wide significant
Table 1. Combined analysis of CD247 polymorphisms according to disease and serological status.
Samples Minor allele (%) Allele test*
Sets N Genotype (%) P-value OR [95% CI] PBD
rs1052231 T/T T/A A/A A
Controls 3994 69.1 27.6 2.9 16.7
RA 3499 69.1 27.7 3.2 17.0 0.595 1.02 [0.94–1.20] 0.117
RA RF + 2094 68.5 28.2 3.3 17.4 0.463 1.04 [0.94–1.15] 0.080
RA RF 2 991 69.1 28.0 2.9 16.9 0.792 1.02 [0.89–1.16] 0.506
RA anti-CCP + 1702 69.2 27.8 3.0 16.9 0.852 0.99 [0.88–1.10] 0.142
RA anti-CCP 2 1013 68.2 29.2 2.6 17.2 0.451 0.95 [0.83–1.08] 0.192
rs864537 A/A A/G G/G G
Controls 3910 38.3 46.8 14.9 38.3
RA 3485 39.0 46.8 14.2 37.6 0.33 0.97 [0.91–1.03] 0.648
RA RF + 2087 39.5 47.1 13.4 37.8 0.060 0.93 [0.86–1.00] 0.509
RA RF 2 982 37.8 46.6 15.6 38.4 0.406 1.04 [0.94–1.56] 0.931
RA anti-CCP + 1699 38.8 47.5 13.7 37.5 0.457 0.97 [0.89–1.05] 0.482
RA anti-CCP 2 1011 40.5 45.5 14.0 36.8 0.309 0.95 [0.86–1.05] 0.844
rs2056626 T/T T/G G/G G
Controls 3888 38.6 46.6 14.8 38.1
RA 3473 39.2 46.8 14.0 37.4 0.348 0.97 [0.91–1.04] 0.051
RA RF + 2082 39.9 45.9 14.3 37.9 0.294 0.96 [0.87–1.04] 0.031
RA RF 2 979 38.4 47.3 14.3 38.1 0.803 1.01 [0.91–1.12] 0.545
RA anti-CCP + 1683 40.6 45.1 14.3 36.9 0.323 0.96 [0.88–1.04] 0.031
RA anti-CCP 2 1005 39.4 47.2 13.4 37.0 0.712 0.98 [0.89–1.09] 0.956
Controls are used as reference for all comparisons.
*Allelic Mantel-Haenszel fixed effects model.
RA, rheumatoid arthritis; RF, rheumatoid factor; anti-CCP, anti-cyclic citrullinated peptide; +, positive; 2, negative; PBD, Breslow-Day P-Value.
doi:10.1371/journal.pone.0068295.t001
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association between rs864537 and RA with anti-CCP (OR=0.90,
Ci 95%=0.87–0.93, Poverall = 2.1610
210) (Figure 1).
The present study represents a good example of how increasing
the study cohort may be necessary to detect genetic associations of
weak effect size at GWAS level. In this regard, the study
performed by Stahl et al. detected no association of CD247 with
RA at GWAS level [6], and the CD247 association only reached
genome-wide significance level when data of two autoimmune
diseases, RA and CeD, were combined [7]. Therefore, the current
study described for first time at GWAS-level association of CD247
and RA risk using a meta-analysis of a large European Caucasian
case-control sample set.
A reduced density of synovial T-cell surface CD3f has been
observed in RA patients [11,12,13], suggesting a decrease in TCR
signaling, thus favoring positive selection of autoreactive T effector
cells in the thymus [14]. It is unclear what is the cause of the low
expression of CD3f in synovial T cells and several possible
mechanisms should be considered [1,11,12,13]. Regarding this,
splicing variants of CD247 have been demonstrated to lead to
downregulated protein expression in SLE patients [1,15]. It is
interesting to note that the risk variant of CD247 rs864537 has also
been correlated with cis gene expression of CD247 [7]. Further
functional studies should shed more light on the role of this genetic
variant in the susceptibility to RA.
Supporting Information
Table S1
(DOC)
Checklist S1
(DOC)
Diagram S1
(DOC)
Acknowledgments
We thank Sofı´a Vargas, Sonia Garcia and Siri Fla˚m for their excellent
technical assistance. We thank Banco Nacional de ADN (University of
Salamanca, Spain) and the Norwegian Bone Marrow Donor Registry who
supplied part of control DNA samples, and all patients and donors for their
collaboration. We also thank Nicola Dalbeth, Peter Gow, Peter Jones,
Andrew Harrison, John Highton and Lisa Stamp for their role in recruiting
New Zealand RA patients.
Author Contributions
Conceived and designed the experiments: MT JM. Performed the
experiments: MT MS BAL. Analyzed the data: MT CM BAL TM.
Wrote the paper: MT. Acquisition of clinical data and interpretation of
data: AB DPS LRR AMO CGV MAGG TW. Revision of the final
manuscript: TW TM BAL JM.
References
1. Takeuchi T, Suzuki K, Kondo T, Yoshimoto K, Tsuzaka K (2012) CD3 zeta
defects in systemic lupus erythematosus. Ann Rheum Dis 71: i78–i81.
2. Gorman CL, Russell AI, Zhang Z, Cunninghame Graham D, Cope AP, et al.
(2008) Polymorphisms in the CD3Z gene influence TCRzeta expression in
systemic lupus erythematosus patients and healthy controls. J Immunol 180:
1060–1070.
Figure 1. Forest plots of the CD247 rs864537 variant in RA patients and healthy subjects including GWAS data from Stahl et al. [6]
and Zhernakova et al. [7]. The combined analysis included a total of 10,763 RA patients with anti-CPP and 28,879 controls. There was no evidence
of heterogeneity between sample sets (Breslow-Day test for heterogeneity p = 0.12).
doi:10.1371/journal.pone.0068295.g001
CD247 Polymorphisms in RA
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e68295
3. Warchol T, Piotrowski P, Lianeri M, Cieslak D, Wudarski M, et al. (2009) The
CD3Z 844 T.A polymorphism within the 3’-UTR of CD3Z confers increased
risk of incidence of systemic lupus erythematosus. Tissue Antigens 74: 68–72.
4. Dieude P, Boileau C, Guedj M, Avouac J, Ruiz B, et al. (2011) Independent
replication establishes the CD247 gene as a genetic systemic sclerosis
susceptibility factor. Ann Rheum Dis 70: 1695–1696.
5. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, et al. (2010)
Genome-wide association study of systemic sclerosis identifies CD247 as a new
susceptibility locus. Nat Genet 42: 426–429.
6. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, et al. (2010) Genome-
wide association study meta-analysis identifies seven new rheumatoid arthritis
risk loci. Nat Genet 42: 508–514.
7. Zhernakova A, Stahl EA, Trynka G, Raychaudhuri S, Festen EA, et al. (2011)
Meta-analysis of genome-wide association studies in celiac disease and
rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 7:
e1002004.
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, et al. (1988) The
American Rheumatism Association 1987 revised criteria for the classification of
rheumatoid arthritis. Arthritis Rheum 31: 315–324.
9. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007)
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 81: 559–575.
10. Skol AD, Scott LJ, Abecasis GR, Boehnke M (2006) Joint analysis is more
efficient than replication-based analysis for two-stage genome-wide association
studies. Nat Genet 38: 209–213.
11. Berg L, Ronnelid J, Klareskog L, Bucht A (2000) Down-regulation of the T cell
receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell
responsiveness. Clin Exp Immunol 120: 174–182.
12. Matsuda M, Ulfgren AK, Lenkei R, Petersson M, Ochoa AC, et al. (1998)
Decreased expression of signal-transducing CD3 zeta chains in T cells from the
joints and peripheral blood of rheumatoid arthritis patients. Scand J Immunol
47: 254–262.
13. Maurice MM, Lankester AC, Bezemer AC, Geertsma MF, Tak PP, et al. (1997)
Defective TCR-mediated signaling in synovial T cells in rheumatoid arthritis.
J Immunol 159: 2973–2978.
14. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, et al. (2003) Altered
thymic T-cell selection due to a mutation of the ZAP-70 gene causes
autoimmune arthritis in mice. Nature 426: 454–460.
15. Takeuchi T, Tsuzaka K, Abe T (2004) Altered expression of the T cell receptor-
CD3 complex in systemic lupus erythematosus. Int Rev Immunol 23: 273–291.
CD247 Polymorphisms in RA
PLOS ONE | www.plosone.org 4 July 2013 | Volume 8 | Issue 7 | e68295
